上海研盟生物有限公司*品質(zhì)供應(yīng)Anti-Galactosidase alpha抗體,我公司銷售國(guó)內(nèi)外科研產(chǎn)品,如生物試劑、生化試劑,一抗二抗,各種標(biāo)記抗體,Elisa酶聯(lián)免疫試劑盒,放免試劑盒,培養(yǎng)基,各種動(dòng)物血清等產(chǎn)品,歡迎廣大新老客戶前來(lái)咨詢訂購(gòu),訂購(gòu):或。
α-半乳糖苷酶抗體,Anti-Galactosidase alpha抗體簡(jiǎn)單介紹:
中文名稱:α-半乳糖苷酶抗體
英文名稱:Anti-Galactosidase alpha抗體
別 名:Galactosidase alpha; Alpha D galactosidase A; Alpha D galactoside galactohydrolase; Melibiase; Alpha galactosidase A; GALA; GLA; GLA protein; AGAL_HUMAN.
此產(chǎn)品本公司有標(biāo)記的一抗出售,相關(guān)標(biāo)記有:Alexa Fluor 350 標(biāo)記、Alexa Fluor 488 標(biāo)記、Alexa Fluor 555 標(biāo)記、Alexa Fluor 647 標(biāo)記、AP標(biāo)記、APC標(biāo)記、Biotin標(biāo)記、Cy3標(biāo)記、Cy5標(biāo)記、Cy5.5標(biāo)記、Cy7標(biāo)記、FITC標(biāo)記、Gold標(biāo)記、HRP標(biāo)記、PE標(biāo)記、PE-Cy3標(biāo)記、PE-CY5標(biāo)記、PE-CY5.5標(biāo)記、PE-CY7標(biāo)記、RBITC標(biāo)記
背景介紹:Galactosidase alpha is involved in the hydrolysis of terminal, non reducing alpha D galactose residues in alpha D galactosides, including galactose oligosaccharides, galactomannans and galactohydrolase. Defects in GLA are the cause of Fabry's disease (FD). FD is a rare X-linked sphingolipidosis disease where glycolipid accumulates in many tissues. Clinical recognition in males results from characteristic skin lesions (angiokeratomas) over the lower trunk. Patients may show ocular deposits, febrile episodes, and burning pain in the extremities. Death results from renal failure, cardiac or cerebral complications of hypertension or other vascular disease. Heterozygous females may exhibit the disorder in an attenuated form, they are more likely to show corneal opacities.
規(guī)格:0.1ml/0.2ml
濃度:1mg/1ml
抗體來(lái)源:本公司抗體有兔來(lái)源和鼠來(lái)源等
克隆類型:兔來(lái)源為多抗,鼠來(lái)源為單抗
產(chǎn)品類型:一抗
α-半乳糖苷酶抗體保存條件:Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
避免反復(fù)凍融,保質(zhì)期一年。
α-半乳糖苷酶抗體,Anti-Galactosidase alpha抗體免疫組化問(wèn)題解答
1、染色過(guò)強(qiáng)?
原 因:抗體濃度過(guò)高或孵育時(shí)間過(guò)長(zhǎng)
解決方法:降低抗體滴度、抗體孵育時(shí)間:室溫1小時(shí)或4度過(guò)夜
原 因:孵育溫度過(guò)高超過(guò)37度
解決方法:一般在室溫20-28度
原 因:DAB顯色時(shí)間過(guò)長(zhǎng)或濃度過(guò)高
解決方法:顯色時(shí)間不超過(guò)5-12分鐘,以顯微鏡下觀察為準(zhǔn)
2、非特異性背景染色?
原 因:操作過(guò)程中沖洗不充分
解決方法:每步?jīng)_洗3次每次5分鐘
原 因:組織中含過(guò)氧化物酶未阻斷
解決方法:可再配置新鮮3%H2O2封閉孵育時(shí)間延長(zhǎng)
原 因:組織中含內(nèi)原性*
解決方法:正常非免疫動(dòng)物血清再封閉
原 因:血清蛋白封閉不充分
解決方法:血清蛋白封閉不充分
α-半乳糖苷酶抗體,Anti-Galactosidase alpha抗體相關(guān)優(yōu)質(zhì)產(chǎn)品:
SSTR1 (somatostatin receptor 1) *受體1(SSTR1)抗體
SSTR2 (somatostatin receptor 2) *受體2抗體
SSTR3 (somatostatin receptor 3) *受體3抗體
SSTR4(somatostatin receptor 4) *受體4抗體
SSTR5 (somatostatin receptor 5) *受體5抗體
STAT1(signal transduceBYK and activatoBYK of transcription 1) 信號(hào)轉(zhuǎn)導(dǎo)與轉(zhuǎn)錄激活因子1抗體
phospho-STAT1(p-Tyr701) 抗磷酸化信號(hào)轉(zhuǎn)導(dǎo)與轉(zhuǎn)錄激活因子1抗體
STAT2 (signal transduceBYK and activatoBYK of transduction2) 信號(hào)轉(zhuǎn)導(dǎo)和轉(zhuǎn)錄激活因子2(STAT2)抗體
STEAP1(Six transmbrane epithelial antigen of the prostate 1) 前列腺跨膜上皮1抗原抗體
phospho-STAT3(pThr705) 抗磷酸化信號(hào)轉(zhuǎn)導(dǎo)和轉(zhuǎn)錄激活因子3抗體
phospho-STAT5a(pThr694) 抗磷酸化信號(hào)轉(zhuǎn)導(dǎo)和轉(zhuǎn)錄激活因子5a抗體
phospho-STAT6(pThr641) 抗磷酸化信號(hào)轉(zhuǎn)導(dǎo)和轉(zhuǎn)錄激活因子6抗體
STAT3 (signal transduceBYK and activatoBYK of transduction 3) 信號(hào)轉(zhuǎn)導(dǎo)和轉(zhuǎn)錄激活因子3抗體
STAT4 (signal transduceBYK and activatoBYK of transduction 4) 信號(hào)轉(zhuǎn)導(dǎo)和轉(zhuǎn)錄激活因子4抗體
STAT5 (signal transduceBYK and activatoBYK of transduction 5) 信號(hào)轉(zhuǎn)導(dǎo)和轉(zhuǎn)錄激活因子5(STAT5)抗體
STAT6 (signal transduceBYK and activatoBYK of transduction 6) 信號(hào)轉(zhuǎn)導(dǎo)和轉(zhuǎn)錄激活因子6抗體
Stra8(Stimulated by retinoic acid gene 8) *激活基因8抗體
STRO-1 一種間充質(zhì)干細(xì)胞抗體
streptomycin *抗體